Search
Search Results
##search.searchResults.foundPlural##
-
THERAPY-RELATED MYELOID NEOPLASM IN NON-HODGKIN LYMPHOMA SURVIVORS
2511PDF: 707HTML: 2281 -
OCCURRENCE OF SECONDARY MALIGNANCIES IN CHRONIC MYELOID LEUKEMIA DURING THERAPY WITH IMATINIB MESYLATE-SINGLE INSTITUTION EXPERIENCE
2168PDF: 1002HTML: 1971Characteristic of study group: 177 -
IMPACT OF COVID-19 ON OUTCOMES OF PATIENTS WITH HEMATOLOGIC MALIGNANCIES: A MULTI-CENTER, RETROSPECTIVE STUDY COVID-19 and hematologic malignancy
1354PDF: 721HTML: 191 -
CAR-T CELL THERAPY FOR T-CELL MALIGNANCIES CAR-T CELL FOR T-CELL MALIGNANCIES
2077PDF: 1929HTML: 143 -
THERAPY-RELATED MYELOID MALIGNANCIES IN MYELOMA
2401PDF: 759HTML: 1721 -
CLONAL HEMATOPOIESIS: ROLE IN HEMATOLOGIC NON-HEMATOLOGIC MALIGNANCIES CLONAL HEMATOPOIESIS AND MALIGNANCIES
1870PDF: 836HTML: 1259 -
TUBERCULOSIS IN PATIENTS WITH HAEMATOLOGICAL MALIGNANCIES
3164PDF: 1189HTML: 8082 -
THE IMPORTANCE OF TARGETED NEXT-GENERATION SEQUENCING USAGE IN CYTOGENETICALLY NORMAL MYELOID MALIGNANCIES Targeted next-generation sequencing usage in cytogenetically normal myeloid malignancies
1431PDF: 500HTML: 241 -
TP53-MUTATED MYELODYSPLASIA AND ACUTE MYELOID LEUKEMIA TP53 in MDS and AML
1984PDF: 1600HTML: 345 -
ESCHERICHIA COLI: AN IMPORTANT PATHOGEN IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES
1770PDF: 688HTML: 2082Untitled: 192Untitled: 139Untitled: 152Untitled: 141Untitled: 145Untitled: 161Untitled: 168 -
TOXICITIES ASSOCIATED WITH CAR-T CELL THERAPIES CAR-T Cell Toxicity
1926PDF: 1355HTML: 246 -
NUTRITIONALLY VARIANT STREPTOCOCCI BACTEREMIA IN CANCER PATIENTS: A RETROSPECTIVE STUDY, 1999-2014
2017PDF: 964HTML: 4051Cover Letter: 205Figure 1: 205Figure 2: 212Table 1: 188 -
OPTIMIZING TREATMENT, MINIMIZING RISK: THERAPEUTIC DRUG MONITORING IN HEMATOLOGICAL MALIGNANCIES
774PDF: 908Suppl. Files: 112HTML: 62 -
WALDENSTROM’S MACROGLOBULINEMIA: AN UPDATE
7197PDF: 2372HTML: 1705Table 1.: 183Table 2.: 199Table 3.: 180Table 4.: 179 -
TRANSCRIPTOME ANALYSIS OF BETA-CATENIN-RELATED GENES IN CD34+ HAEMATOPOIETIC STEM AND PROGENITOR CELLS FROM PATIENTS WITH AML Transcriptome analysis of beta-catenin-related genes in AML
960PDF: 1086Suppl. Files: 551HTML: 72 -
RARE CYTOGENETIC ABNORMALITIES IN MYELODYSPLASTIC SYNDROMES
3631PDF: 1603HTML: 11482Figures Haase: 177 -
Glucocorticoids and antivirals for HBV reactivation in onco-hematologic patients
890PDF: 558HTML: 2178Cover Letter: 174 -
SIMILARITIES OF ELDERLY AND THERAPY-RELATED AML
3500PDF: 834HTML: 6695 -
UPDATE ON CYTOMEGALOVIRUS INFECTION MANAGEMENT IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS A Consensus Document of the Spanish Group for Hematopoietic Transplantation and Cell Therapy (GETH-TC)
3747Suppl. Files: 1047PDF: 1020Html: 107 -
ANTIFUNGAL PROPHYLAXIS IN IMMUNOCOMPROMISED PATIENTS
4192PDF: 1333HTML: 2025 -
NOVEL DRUGS IN FOLLICULAR LYMPHOMA
4242PDF: 1449HTML: 1531Untitled: 210 -
UPDATE ON THE LABORATORY DIAGNOSIS OF INVASIVE FUNGAL INFECTIONS
2307PDF: 1358HTML: 1960 -
NF- ?B Essential Modulator Deficiency Leading to Disseminated Cutaneous Atypical Mycobacteria
1619PDF: 1059HTML: 10688Untitled: 163







